Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Analgesic   Parecoxib sodium  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Bextra Brazil
Dynastat Australia, Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Romania, Spain, Sweden, Switzerland, United Arab Emirates, United States of America, Venezuela
Parecoxib BPH Chile
Pro-Bextra Chile
Rayzon Ireland, Netherlands, Sweden
Valdyne Colombia
Valsafe India
Valto P India
Valus P India
Xapit Ireland, Netherlands
Stability in solutions   Injection   Stability in solutions : Parecoxib sodium     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 16 & 20 mg/ml 25°C Light
48 Hour
1824
Level of evidence A
Glass Sodium chloride 0,9% 16 & 20 mg/ml 5°C Protect from light
48 Hour
1824
Level of evidence A
Glass Glucose 5% 16 & 20 mg/ml 25°C Light
48 Hour
1824
Level of evidence A
Glass Glucose 5% 16 & 20 mg/ml 5°C Protect from light
48 Hour
1824
Level of evidence A
Glass NaCl 0,9% + antibacterial 16 & 20 mg/ml 25°C Light
48 Hour
1824
Level of evidence A
Glass NaCl 0,9% + antibacterial 16 & 20 mg/ml 5°C Protect from light
48 Hour
1824
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 13,3 & 20 mg/ml 25°C Light
48 Hour
1824
Level of evidence A
Polypropylen Syringe Sodium chloride 0,9% 13,3 & 20 mg/ml 5°C Protect from light
48 Hour
1824
Level of evidence A
Polypropylen Syringe Glucose 5% 13,3 & 20 mg/ml 25°C Light
48 Hour
1824
Level of evidence A
Polypropylen Syringe Glucose 5% 13,3 & 20 mg/ml 5°C Protect from light
48 Hour
1824
Level of evidence A
Polypropylen Syringe NaCl 0,9% + antibacterial 13,3 & 20 mg/ml 25°C Light
48 Hour
1824
Level of evidence A
Polypropylen Syringe NaCl 0,9% + antibacterial 13,3 & 20 mg/ml 5°C Protect from light
48 Hour
1824
Level of evidence A
  Mentions Légales